Your browser doesn't support javascript.
loading
Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management.
d'Aquino, Andrea I; Maikawa, Caitlin L; Nguyen, Leslee T; Lu, Katie; Hall, Ian A; Jons, Carolyn K; Kasse, Catherine M; Yan, Jerry; Prossnitz, Alexander N; Chang, Enmian; Baker, Sam W; Hovgaard, Lars; Steensgaard, Dorte B; Andersen, Hanne B; Simonsen, Lotte; Appel, Eric A.
Afiliação
  • d'Aquino AI; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA.
  • Maikawa CL; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
  • Nguyen LT; Department of Biochemistry, Stanford University, Palo Alto, CA 94305, USA.
  • Lu K; Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Hall IA; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
  • Jons CK; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA.
  • Kasse CM; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA.
  • Yan J; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
  • Prossnitz AN; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA.
  • Chang E; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA.
  • Baker SW; Department of Comparative Medicine, Stanford University, Palo Alto, CA 94305, USA.
  • Hovgaard L; Department of Biophysics and Formulations, Global Research Technologies, Novo Nordisk Park, 2760 Maaloev, Denmark.
  • Steensgaard DB; Department of Biophysics and Formulations, Global Research Technologies, Novo Nordisk Park, 2760 Maaloev, Denmark.
  • Andersen HB; Department of Biophysics and Formulations, Global Research Technologies, Novo Nordisk Park, 2760 Maaloev, Denmark.
  • Simonsen L; Department of Obesity Research, Global Drug Discovery, Novo Nordisk Park, 2760 Maaloev, Denmark.
  • Appel EA; Department of Materials Science & Engineering, Stanford University, Stanford, CA 94025, USA; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA; ChEM-H Institute, Stanford University, Stanford, CA 94305, USA; Department of Pediatrics (Endocrinology), Stanford University,
Cell Rep Med ; 4(11): 101292, 2023 11 21.
Article em En | MEDLINE | ID: mdl-37992687

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article